What Researchers Did
Researchers conducted a randomized controlled trial with 184 chronic subdural hematoma patients to evaluate the effects of hyperbaric oxygen therapy combined with a Medical-Psychosocial-Nursing Functional Support model on postoperative recovery and recurrence.
What They Found
The observation group, receiving hyperbaric oxygen therapy and MPNFS, demonstrated significantly better 1-month outcomes, including lower NIHSS scores (1.89 ± 0.82 vs. 3.51 ± 1.05), higher FMA scores (78.25 ± 5.61 vs. 65.37 ± 6.02), and improved SF-36 scores (85.39 ± 4.73 vs. 73.18 ± 5.29). This group also experienced fewer complications (10.87% vs. 27.17%) and a substantially lower 6-month recurrence rate (5.43% vs. 19.57%) compared to the control group.
What This Means for Canadian Patients
For Canadian patients undergoing chronic subdural hematoma surgery, this study suggests that adding hyperbaric oxygen therapy and a comprehensive nursing model could lead to better neurological and motor recovery. This combined approach may also reduce the risk of postoperative complications and recurrence, potentially improving long-term quality of life.
Canadian Relevance
This study has no direct Canadian connection or specific relevance to Canadian healthcare policies or patient populations.
Study Limitations
The study's findings may be limited by its single-center design and the relatively short 6-month follow-up period for recurrence assessment.